InvestorsHub Logo
Followers 64
Posts 6479
Boards Moderated 0
Alias Born 03/17/2017

Re: IkeEsq post# 399522

Friday, 09/03/2021 5:29:13 AM

Friday, September 03, 2021 5:29:13 AM

Post# of 700894

Ha, ha, ha, ha, ha! People kill me. What is your claim?



actually, Happy was referring to § 11.42, clinical trial results information specified in sections 402(j)(3)(C) and 402(j)(3)(I) of the Public Health Service Act (42 U.S.C. 282(j)(3)(C) and 42 U.S.C. 282(j)(3)(I)) or in § 11.48, as applicable.

In other words, he wants to poke the NIH with legal measures to enforce that law. But I agree with Flipper its toothless although there has been one recent case in particular where management of a biotech refusing to release topline months after being warned by the NIH got much more than just a fine after a verdict.

I have posted that particular case before here will look it up again.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News